Institutional members access full text with Ovid®

Share this article on:

In Vivo Inferiority of Generic Product Compared With Branded Vancomycin: A Paradigm Shift

Jong, G. W.'t MD, PhD

Therapeutic Drug Monitoring: February 2012 - Volume 34 - Issue 1 - p 2-3
doi: 10.1097/FTD.0b013e318243e739
TDM Journal Club

Division of Clinical Pharmacology & Toxicology, Hospital for Sick Children, Toronto, Ontario, Canada

Supported by educational and research grants from Ter Meulen Fund, Royal Netherlands Academy of Arts and Sciences, the Netherlands, and Netherlands Society for Clinical Pharmacology & Biopharmacy.

The authors declare no conflict of interest.

Correspondence: G. W. 't Jong, MD, PhD, Division of Clinical Pharmacology & Toxicology, Hospital for Sick Children, 8224, 555 University Avenue, Toronto, ON, Canada M5G 1X8 (e-mail: geertwtjong@gmail.com).

© 2012 Lippincott Williams & Wilkins, Inc.